OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Phase Ib study of anlotinib in combination with anti‐PD‐L1 antibody (TQB2450 ) in patients with advanced acral melanoma
Yu Du, Jie Dai, Lili Mao, et al.
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 38, Iss. 1, pp. 93-101
Closed Access | Times Cited: 6
Yu Du, Jie Dai, Lili Mao, et al.
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 38, Iss. 1, pp. 93-101
Closed Access | Times Cited: 6
Showing 6 citing articles:
Efficacy and safety of TQB2450 combined with anlotinib as maintenance therapy for LS-SCLC after definitive concurrent or sequential chemoradiotherapy: a prospective phase Ib study
Xiaoteng Ma, Xiaoyan Yin, Lulu Zhuang, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Xiaoteng Ma, Xiaoyan Yin, Lulu Zhuang, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Combination of anlotinib with immunotherapy enhanced both anti-angiogenesis and immune response in high-grade serous ovarian cancer
Hongwei Lan, Hui Liu, Helei Hou, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Hongwei Lan, Hui Liu, Helei Hou, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironment
Eric A. Smith, R.L. Belote, Nelly M. Cruz, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Eric A. Smith, R.L. Belote, Nelly M. Cruz, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Updates on altered signaling pathways in tumor drug resistance
Xiuzhi Li, Xin Huang, Ming Chang, et al.
Visualized Cancer Medicine (2024) Vol. 5, pp. 6-6
Open Access
Xiuzhi Li, Xin Huang, Ming Chang, et al.
Visualized Cancer Medicine (2024) Vol. 5, pp. 6-6
Open Access
TQB2450 with or without anlotinib as maintenance treatment in subjects with locally advanced/unresectable non-small cell lung cancer that have not progressed after prior concurrent/sequential chemoradiotherapy (R-ALPS): study protocol for a randomized, double-blind, placebo-controlled, multicenter phase III trial
Baiqiang Dong, Long Chen, Qingsong Pang, et al.
Translational Lung Cancer Research (2024) Vol. 13, Iss. 10, pp. 2828-2837
Open Access
Baiqiang Dong, Long Chen, Qingsong Pang, et al.
Translational Lung Cancer Research (2024) Vol. 13, Iss. 10, pp. 2828-2837
Open Access
Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironment
Eric A. Smith, R.L. Belote, Nelly M. Cruz, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access
Eric A. Smith, R.L. Belote, Nelly M. Cruz, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access
